Skip to main content
Top
Published in: Clinical and Experimental Nephrology 3/2018

01-06-2018 | Original article

Cardiovascular disease in kidney transplant recipients: Japan Academic Consortium of Kidney Transplantation (JACK) cohort study

Published in: Clinical and Experimental Nephrology | Issue 3/2018

Login to get access

Abstract

Background

The number of kidney transplant recipients (KTRs) from diabetic nephropathy (DN) and with cardiovascular disease (CVD) history has increased worldwide. Nevertheless, epidemiologic evidence of CVD in KTRs remains limited.

Methods

We investigated post-transplant CVD in 1614 adult KTRs between 1990 and 2014. CVD was defined according to the international classification of diseases (ICD-10). All-cause mortality was also investigated. Final follow-up was performed in March 2016. The KTRs were categorized into four groups according to DN and CVD at surgery.

Results

During the follow-up period, 309 KTRs experienced CVDs and 124 KTRs died. The 15-year cumulative CVDs rate was 87% in KTRs with both DN and CVD history, and the rate in KTRs without those was 22.3%. DN and CVD were associated with increased risk of post-transplant CVD [hazard ratio (HR), 3.44; 95% confidence interval (CI), 2.03–5.82; P < 0.001], and the impact marked increased after 7.5 years follow-up period (HR, 16.56; 95% CI, 6.56–41.8; P < 0.001). DN and CVD in KTRs were associated with mortality (HR, 3.32; 95% CI, 1.34–8.22; P = 0.009), and post-transplant CVD was the leading cause (35.5%) of overall death. However, DN and CVD were not associated with increased graft failure rate.

Conclusions

The risk of post-transplant CVDs incidence in KTRs with DN and CVD history is high, and it increases during the late transplant period. Appropriate routine cardiovascular screening and evaluation are needed to reduce late-onset CVD incidence.
Literature
1.
go back to reference Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28–292.CrossRefPubMed Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28–292.CrossRefPubMed
2.
go back to reference Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100(10):1134–46.CrossRefPubMed Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100(10):1134–46.CrossRefPubMed
3.
go back to reference Chang SH, Russ GR, Chadban SJ, Campbell SB, McDonald SP. Trends in kidney transplantation in Australia and New Zealand, 1993–2004. Transplantation. 2007;84(5):611–8.CrossRefPubMed Chang SH, Russ GR, Chadban SJ, Campbell SB, McDonald SP. Trends in kidney transplantation in Australia and New Zealand, 1993–2004. Transplantation. 2007;84(5):611–8.CrossRefPubMed
4.
go back to reference Lim WH, Wong G, Pilmore HL, McDonald SP, Chadban SJ. Long-term outcomes of kidney transplantation in people with type 2 diabetes: a population cohort study. Lancet Diabetes Endocrinol. 2017;5(1):26–33.CrossRefPubMed Lim WH, Wong G, Pilmore HL, McDonald SP, Chadban SJ. Long-term outcomes of kidney transplantation in people with type 2 diabetes: a population cohort study. Lancet Diabetes Endocrinol. 2017;5(1):26–33.CrossRefPubMed
5.
go back to reference Israni AK, Snyder JJ, Skeans MA, Peng Y, Maclean JR, Weinhandl ED, et al. Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) Study. Am J Transplant. 2010;10(2):338–53.CrossRefPubMed Israni AK, Snyder JJ, Skeans MA, Peng Y, Maclean JR, Weinhandl ED, et al. Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) Study. Am J Transplant. 2010;10(2):338–53.CrossRefPubMed
6.
go back to reference Jardine AG, Gaston RS, Fellstrom BC, Holdaas H. Prevention of cardiovascular disease in adult recipients of kidney transplants. Lancet. 2011;378(9800):1419–27.CrossRefPubMed Jardine AG, Gaston RS, Fellstrom BC, Holdaas H. Prevention of cardiovascular disease in adult recipients of kidney transplants. Lancet. 2011;378(9800):1419–27.CrossRefPubMed
7.
go back to reference Kidney Disease: Improving Global Outcomes Transplant Work G. KDIGO. clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9(Suppl 3):S1–155. Kidney Disease: Improving Global Outcomes Transplant Work G. KDIGO. clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9(Suppl 3):S1–155.
8.
go back to reference Tanaka K, Watanabe T, Takeuchi A, Ohashi Y, Nitta K, Akizawa T, et al. Cardiovascular events and death in Japanese patients with chronic kidney disease. Kidney Int. 2017;91(1):227–34.CrossRefPubMed Tanaka K, Watanabe T, Takeuchi A, Ohashi Y, Nitta K, Akizawa T, et al. Cardiovascular events and death in Japanese patients with chronic kidney disease. Kidney Int. 2017;91(1):227–34.CrossRefPubMed
9.
go back to reference Okumi M, Unagami K, Tachibana H, Hirai T, Ishida H, Tanabe K, et al. Association between body mass index and outcomes in Japanese living kidney transplant recipients: the role of sex differences. Int J Urol. 2016;23(9):776–84.CrossRefPubMed Okumi M, Unagami K, Tachibana H, Hirai T, Ishida H, Tanabe K, et al. Association between body mass index and outcomes in Japanese living kidney transplant recipients: the role of sex differences. Int J Urol. 2016;23(9):776–84.CrossRefPubMed
11.
go back to reference Okumi M, Toki D, Nozaki T, Shimizu T, Shirakawa H, Omoto K, et al. ABO-Incompatible living kidney transplants: Evolution of Outcomes and Immunosuppressive Management. Am J Transplant. 2016;16(3):886–96.CrossRefPubMed Okumi M, Toki D, Nozaki T, Shimizu T, Shirakawa H, Omoto K, et al. ABO-Incompatible living kidney transplants: Evolution of Outcomes and Immunosuppressive Management. Am J Transplant. 2016;16(3):886–96.CrossRefPubMed
12.
go back to reference Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–92.CrossRefPubMed Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–92.CrossRefPubMed
13.
go back to reference Lam NN, Kim SJ, Knoll GA, McArthur E, Lentine KL, Naylor KL, et al. The risk of cardiovascular disease is not increasing over time despite aging and higher comorbidity burden of kidney transplant recipients. Transplantation. 2017;101(3):588–96.CrossRefPubMed Lam NN, Kim SJ, Knoll GA, McArthur E, Lentine KL, Naylor KL, et al. The risk of cardiovascular disease is not increasing over time despite aging and higher comorbidity burden of kidney transplant recipients. Transplantation. 2017;101(3):588–96.CrossRefPubMed
14.
go back to reference Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant. 2004;4(3):378–83.CrossRefPubMed Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant. 2004;4(3):378–83.CrossRefPubMed
15.
go back to reference Weiner DE, Carpenter MA, Levey AS, Ivanova A, Cole EH, Hunsicker L, et al. Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial. Am J Transplant. 2012;12(9):2437–45.CrossRefPubMedPubMedCentral Weiner DE, Carpenter MA, Levey AS, Ivanova A, Cole EH, Hunsicker L, et al. Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial. Am J Transplant. 2012;12(9):2437–45.CrossRefPubMedPubMedCentral
16.
go back to reference Briggs JD. Causes of death after renal transplantation. Nephrol Dial Transplant. 2001;16(8):1545–9.CrossRefPubMed Briggs JD. Causes of death after renal transplantation. Nephrol Dial Transplant. 2001;16(8):1545–9.CrossRefPubMed
17.
go back to reference Writing Group M, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, et al. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016;133(4):e38–60.CrossRef Writing Group M, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, et al. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016;133(4):e38–60.CrossRef
18.
go back to reference Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2003;14(12):3270–7.CrossRefPubMed Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2003;14(12):3270–7.CrossRefPubMed
19.
go back to reference Yoshino M, Kuhlmann MK, Kotanko P, Greenwood RN, Pisoni RL, Port FK, et al. International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. J Am Soc Nephrol. 2006;17(12):3510–9.CrossRefPubMed Yoshino M, Kuhlmann MK, Kotanko P, Greenwood RN, Pisoni RL, Port FK, et al. International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. J Am Soc Nephrol. 2006;17(12):3510–9.CrossRefPubMed
20.
go back to reference Lentine KL, Costa SP, Weir MR, Robb JF, Fleisher LA, Kasiske BL, et al. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation: endorsed by the American Society of Transplant Surgeons, American Society of Transplantation, and National Kidney Foundation. Circulation. 2012;126(5):617–63.CrossRefPubMed Lentine KL, Costa SP, Weir MR, Robb JF, Fleisher LA, Kasiske BL, et al. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation: endorsed by the American Society of Transplant Surgeons, American Society of Transplantation, and National Kidney Foundation. Circulation. 2012;126(5):617–63.CrossRefPubMed
21.
go back to reference de Mattos AM, Prather J, Olyaei AJ, Shibagaki Y, Keith DS, Mori M, et al. Cardiovascular events following renal transplantation: role of traditional and transplant-specific risk factors. Kidney Int. 2006;70(4):757–64.CrossRefPubMed de Mattos AM, Prather J, Olyaei AJ, Shibagaki Y, Keith DS, Mori M, et al. Cardiovascular events following renal transplantation: role of traditional and transplant-specific risk factors. Kidney Int. 2006;70(4):757–64.CrossRefPubMed
22.
go back to reference Okumi M, Unagami K, Hirai T, Shimizu T, Ishida H, Tanabe K, et al. Diabetes mellitus after kidney transplantation in Japanese patients: The Japan Academic Consortium of Kidney Transplantation study. Int J Urol. 2017;24(3):197–204.CrossRefPubMed Okumi M, Unagami K, Hirai T, Shimizu T, Ishida H, Tanabe K, et al. Diabetes mellitus after kidney transplantation in Japanese patients: The Japan Academic Consortium of Kidney Transplantation study. Int J Urol. 2017;24(3):197–204.CrossRefPubMed
23.
go back to reference Kajimoto K, Sato N, Takano T, Investigators A. eGFR and Outcomes in Patients with Acute Decompensated Heart Failure with or without Elevated BUN. Clin J Am Soc Nephrol. 2016;11(3):405–12.CrossRefPubMedPubMedCentral Kajimoto K, Sato N, Takano T, Investigators A. eGFR and Outcomes in Patients with Acute Decompensated Heart Failure with or without Elevated BUN. Clin J Am Soc Nephrol. 2016;11(3):405–12.CrossRefPubMedPubMedCentral
24.
go back to reference Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108(17):2154–69.CrossRefPubMed Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108(17):2154–69.CrossRefPubMed
25.
go back to reference Minami Y, Kajimoto K, Sato N, Hagiwara N, Takano T, Investigators As. End-stage renal disease patients on chronic maintenance hemodialysis in a hospitalized acute heart failure cohort: prevalence, clinical characteristics, therapeutic options, and mortality. Int J Cardiol. 2016;224:267–70.CrossRefPubMed Minami Y, Kajimoto K, Sato N, Hagiwara N, Takano T, Investigators As. End-stage renal disease patients on chronic maintenance hemodialysis in a hospitalized acute heart failure cohort: prevalence, clinical characteristics, therapeutic options, and mortality. Int J Cardiol. 2016;224:267–70.CrossRefPubMed
26.
go back to reference Di Lullo L, Rivera R, Barbera V, Bellasi A, Cozzolino M, Russo D, et al. Sudden cardiac death and chronic kidney disease: from pathophysiology to treatment strategies. Int J Cardiol. 2016;217:16–27.CrossRefPubMed Di Lullo L, Rivera R, Barbera V, Bellasi A, Cozzolino M, Russo D, et al. Sudden cardiac death and chronic kidney disease: from pathophysiology to treatment strategies. Int J Cardiol. 2016;217:16–27.CrossRefPubMed
27.
go back to reference Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S112–9.CrossRefPubMed Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S112–9.CrossRefPubMed
Metadata
Title
Cardiovascular disease in kidney transplant recipients: Japan Academic Consortium of Kidney Transplantation (JACK) cohort study
Publication date
01-06-2018
Published in
Clinical and Experimental Nephrology / Issue 3/2018
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-017-1500-z

Other articles of this Issue 3/2018

Clinical and Experimental Nephrology 3/2018 Go to the issue